Spots Global Cancer Trial Database for hiv infection
Every month we try and update this database with for hiv infection cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist | NCT00001475 | Acquired Immuno... HIV Infection | IL-2 plus Anti-... | - | National Institutes of Health Clinical Center (CC) | |
Viral Load Determination and Biomarkers of High Risk Human Papillomavirus (HPV) - Types in HIV-positive Men | NCT00365729 | HIV Infections Papillomavirus ... Anal Intraepith... | Smear and biops... | 18 Years - | Deutsche Luft und Raumfahrt | |
Human Papillomavirus Infection and Knowledge and Attitudes About HPV Vaccines Among Men Who Have Sex With Men (MSM) | NCT01300689 | HPV Infection HIV Infection Syphilis | 18 Years - | ChineseAMS | ||
Viral Load Determination and Biomarkers of High Risk Human Papillomavirus (HPV) - Types in HIV-positive Men | NCT00365729 | HIV Infections Papillomavirus ... Anal Intraepith... | Smear and biops... | 18 Years - | Deutsche Luft und Raumfahrt | |
Incidence and Prevalence of Cancer in People Living With HIV/AIDS at Cancer Centers in Latin America | NCT04089488 | HIV Infection Human Immunodef... Malignant Neopl... Recurrent Malig... | Medical Chart R... Survey Administ... | 18 Years - | AIDS Malignancy Consortium | |
Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection | NCT03677960 | HSIL, High-Grad... Human Papilloma... HIV Infection Anal Cancer Anus Neoplasm | Topical ABI-196... | 27 Years - | Antiva Biosciences | |
Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer | NCT00005785 | Hematologic Neo... HIV Infection | GCSF Mobilized ... | - | National Institutes of Health Clinical Center (CC) | |
A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults | NCT00798265 | Human Immunodef... Human Papilloma... Adolescent Papillomavirus ... | Gardasil Survey | 12 Years - 26 Years | National Institutes of Health Clinical Center (CC) | |
Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers | NCT04083170 | Acute Erythroid... Acute Lymphobla... Acute Megakaryo... Acute Myeloid L... Chronic Myeloge... Hematopoietic a... HIV Infection Myelodysplastic... Myelodysplastic... Non-Hodgkin Lym... Refractory Anem... | Fludarabine Cyclophosphamid... Thiotepa Total-Body Irra... Umbilical Cord ... Dilanubicel | 6 Months - 65 Years | Fred Hutchinson Cancer Center | |
Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma | NCT00981097 | Lymphoma Nonneoplastic C... | polymerase chai... laboratory biom... | 18 Years - | AIDS Malignancy Consortium | |
Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits | NCT00001500 | Acquired Immuno... Alcoholism HIV Infection Neoplasm Smoking | - | National Institutes of Health Clinical Center (CC) | ||
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery | NCT02408861 | Advanced Malign... Anal Carcinoma HIV Infection Kaposi Sarcoma Lung Carcinoma Metastatic Mali... Recurrent Class... Refractory Clas... Unresectable So... | Biospecimen Col... Bone Marrow Bio... Computed Tomogr... Ipilimumab Nivolumab Positron Emissi... | 18 Years - | National Cancer Institute (NCI) | |
Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma | NCT01771107 | AIDS-Related Ho... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Classic Hodgkin... HIV Infection | Brentuximab Ved... Dacarbazine Doxorubicin Hyd... Pharmacological... Vinblastine | 18 Years - | National Cancer Institute (NCI) | |
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma | NCT01016730 | AIDS-Related Ka... HIV Infection Recurrent Kapos... | Bortezomib Laboratory Biom... Questionnaire A... | 18 Years - | National Cancer Institute (NCI) | |
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV | NCT04514484 | Advanced Differ... Advanced Head a... Advanced Hepato... Advanced Kaposi... Advanced Lung N... Advanced Lung S... Advanced Malign... Advanced Melano... Advanced Ovaria... Advanced Prosta... Advanced Renal ... Advanced Thyroi... Advanced Triple... Advanced Urothe... Anatomic Stage ... Anatomic Stage ... Castration-Resi... Clinical Stage ... Clinical Stage ... HIV Infection Metastatic Diff... Metastatic Head... Metastatic Hepa... Metastatic Kapo... Metastatic Lung... Metastatic Lung... Metastatic Mali... Metastatic Mela... Metastatic Ovar... Metastatic Pros... Metastatic Rena... Metastatic Thyr... Metastatic Trip... Metastatic Urot... Recurrent Diffe... Recurrent Head ... Recurrent Hepat... Recurrent Kapos... Recurrent Lung ... Recurrent Lung ... Recurrent Malig... Recurrent Melan... Recurrent Ovari... Recurrent Prost... Recurrent Renal... Recurrent Thyro... Recurrent Tripl... Recurrent Uroth... Refractory Diff... Stage III Diffe... Stage III Hepat... Stage III Lung ... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Thyro... Stage IV Differ... Stage IV Hepato... Stage IV Lung C... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Thyroi... | Biospecimen Col... Cabozantinib S-... Computed Tomogr... Magnetic Resona... Nivolumab | 18 Years - | National Cancer Institute (NCI) | |
NT-I7 for Kaposi Sarcoma in Patients With or Without HIV | NCT04893018 | AIDS-Related Ka... HIV Infection Kaposi Sarcoma | Efineptakin alf... | 18 Years - | Fred Hutchinson Cancer Center | |
Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers | NCT04083170 | Acute Erythroid... Acute Lymphobla... Acute Megakaryo... Acute Myeloid L... Chronic Myeloge... Hematopoietic a... HIV Infection Myelodysplastic... Myelodysplastic... Non-Hodgkin Lym... Refractory Anem... | Fludarabine Cyclophosphamid... Thiotepa Total-Body Irra... Umbilical Cord ... Dilanubicel | 6 Months - 65 Years | Fred Hutchinson Cancer Center | |
Re-Evaluation of Annual Cytology Using HPV Testing to Upgrade Prevention in Women Living With HIV | NCT04155294 | Cervical Cancer HPV Infection HIV Infections | 25 Years - 64 Years | University of Oxford | ||
Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection | NCT02437851 | Anal Squamous C... HIV Infection Stage 0 Anal Ca... Stage I Anal Ca... | Therapeutic Con... | 18 Years - | AIDS Malignancy Consortium | |
Health-Related Symptom Questionnaires in Measuring Quality of Life in HIV-Infected Participants Treated or Monitored for Anal Lesions | NCT02418494 | High Grade Anal... HIV Infection | Concept Elicita... Comprehension A... | 35 Years - | AIDS Malignancy Consortium | |
Development of Serologic Assays for Human Herpes Virus-8 | NCT00395278 | Kaposi Sarcoma HIV Infection | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | ||
Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer | NCT01590017 | Cervical Cancer Acquired Immuno... | cisplatin external beam r... | 18 Years - 120 Years | AIDS Malignancy Consortium | |
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer | NCT04929028 | AIDS-Related An... Anal Basaloid S... Anal Canal Cloa... Anal Margin Squ... Anal Squamous C... HIV Infection Rectal Squamous... Stage I Anal Ca... Stage II Anal C... Stage II Rectal... Stage III Anal ... Stage III Recta... | Capecitabine Fluorouracil Intensity-Modul... Mitomycin Nivolumab | 18 Years - | National Cancer Institute (NCI) | |
Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males | NCT01209325 | Anal Cancer Nonneoplastic C... Penile Cancer Precancerous Co... | quadrivalent hu... laboratory biom... | 13 Years - 26 Years | AIDS Malignancy Consortium | |
Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma | NCT02137564 | AIDS-related Ka... HIV Infection Recurrent Kapos... | gamma secretase... pharmacological... laboratory biom... | 18 Years - | AIDS Malignancy Consortium | |
Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy | NCT01319526 | Lymphoma Nonneoplastic C... | DNA analysis RNA analysis laboratory biom... | 18 Years - | AIDS Malignancy Consortium | |
Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist | NCT00001475 | Acquired Immuno... HIV Infection | IL-2 plus Anti-... | - | National Institutes of Health Clinical Center (CC) | |
Cabozantinib S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus | NCT01822522 | Advanced Malign... HIV Infection Metastatic Mali... Recurrent Malig... Unresectable So... | Cabozantinib S-... Laboratory Biom... Pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection | NCT02134886 | HIV Infection Recurrent Non-S... Stage IIIA Non-... Stage IIIB Non-... Stage IV Non-Sm... | Erlotinib Hydro... Laboratory Biom... Pharmacological... Quality-of-Life... | 18 Years - | National Cancer Institute (NCI) | |
Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women | NCT03834571 | Cervical Adenoc... Cervical Adenos... Cervical Squamo... FIGO Stage IIB ... FIGO Stage III ... FIGO Stage IVA ... HIV Infection | Carboplatin Cisplatin Paclitaxel Patient Monitor... Radiation Thera... | 18 Years - | AIDS Malignancy Consortium | |
S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma | NCT00822120 | Lymphoma Nonneoplastic C... | bleomycin sulfa... filgrastim ABVD regimen BEACOPP regimen cyclophosphamid... dacarbazine doxorubicin hyd... etoposide prednisone procarbazine hy... vinblastine sul... vincristine sul... | 18 Years - 60 Years | SWOG Cancer Research Network | |
Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection | NCT02134886 | HIV Infection Recurrent Non-S... Stage IIIA Non-... Stage IIIB Non-... Stage IV Non-Sm... | Erlotinib Hydro... Laboratory Biom... Pharmacological... Quality-of-Life... | 18 Years - | National Cancer Institute (NCI) | |
Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men | NCT04142398 | HIV Infection Human Papilloma... Human Papilloma... | Cytology Specim... High Resolution... Laboratory Biom... Medical Examina... Physical Examin... Questionnaire A... | 18 Years - | AIDS Malignancy Consortium | |
Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia | NCT01164722 | Anal Cancer Neoplasm of Unc... Nonneoplastic C... Precancerous Co... | clinical observ... infrared photoc... | 27 Years - | AIDS Malignancy Consortium | |
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials | NCT01946217 | HIV Infection Malignant Neopl... Precancerous Co... | questionnaire a... | 18 Years - | AIDS Malignancy Consortium | |
Gene-Modified HIV-Protected Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma | NCT02378922 | AIDS-Related Ho... AIDS-Related No... HIV Infection Recurrent Hodgk... Recurrent Non-H... | Gene-Modified H... Laboratory Biom... Transplant Cond... | 18 Years - 66 Years | Fred Hutchinson Cancer Center | |
Cohort of HIV Associated Lymphomas | NCT01164436 | HIV Infection | 18 Years - 65 Years | ANRS, Emerging Infectious Diseases | ||
Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV | NCT01946139 | Anal Cancer HIV Infection Human Papilloma... | comparison of s... laboratory biom... questionnaire a... quality-of-life... | 18 Years - | AIDS Malignancy Consortium | |
Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy | NCT01319526 | Lymphoma Nonneoplastic C... | DNA analysis RNA analysis laboratory biom... | 18 Years - | AIDS Malignancy Consortium | |
A Phase II Trial of COL-3 in Patients With HIV Related Kaposi's Sarcoma | NCT00020683 | AIDS-related Ka... HIV Infection | incyclinide incyclinide laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers | NCT04083170 | Acute Erythroid... Acute Lymphobla... Acute Megakaryo... Acute Myeloid L... Chronic Myeloge... Hematopoietic a... HIV Infection Myelodysplastic... Myelodysplastic... Non-Hodgkin Lym... Refractory Anem... | Fludarabine Cyclophosphamid... Thiotepa Total-Body Irra... Umbilical Cord ... Dilanubicel | 6 Months - 65 Years | Fred Hutchinson Cancer Center | |
HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPV | NCT03284866 | AIDS-Related Hu... High Grade Cerv... HIV Infection | Laboratory Biom... Recombinant Hum... Saline | 25 Years - | AIDS Malignancy Consortium | |
Seville Cohort of People Living With HIV at Risk for Anal Cancer | NCT03713229 | Anal Squamous I... | Screening for a... | 18 Years - | Hospitales Universitarios Virgen del Rocío | |
Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients | NCT01022905 | HIV Infection Rheumatic Disea... Cancer Transplant Pediatrics | Adjuvanted infl... | 6 Months - | University Hospital, Geneva | |
Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer | NCT02595866 | AIDS-Related No... Clinical Stage ... Clinical Stage ... Hepatocellular ... HIV Infection Kaposi Sarcoma Locally Advance... Locally Advance... Metastatic Lung... Metastatic Mali... Metastatic Mela... Non-Hodgkin Lym... Recurrent Class... Recurrent Malig... Refractory Clas... Refractory Mali... Stage III Lung ... Stage IV Lung C... Unresectable Me... | Antiretroviral ... Biopsy Biospecimen Col... Computed Tomogr... Pembrolizumab Positron Emissi... | 18 Years - | National Cancer Institute (NCI) | |
Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant | NCT02797470 | HIV Infection Mature T-Cell a... Plasmablastic L... Recurrent Adult... Recurrent Adult... Recurrent Burki... Recurrent Folli... Stage III Folli... Stage III Mantl... Stage IV Follic... Stage IV Mantle... | Autologous Hema... Carmustine Cytarabine Etoposide Laboratory Biom... Lentivirus Vect... Melphalan Peripheral Bloo... | 18 Years - | AIDS Malignancy Consortium | |
Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients | NCT01022905 | HIV Infection Rheumatic Disea... Cancer Transplant Pediatrics | Adjuvanted infl... | 6 Months - | University Hospital, Geneva | |
Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia | NCT01164722 | Anal Cancer Neoplasm of Unc... Nonneoplastic C... Precancerous Co... | clinical observ... infrared photoc... | 27 Years - | AIDS Malignancy Consortium | |
Human Papillomavirus Infection and Knowledge and Attitudes About HPV Vaccines Among Men Who Have Sex With Men (MSM) | NCT01300689 | HPV Infection HIV Infection Syphilis | 18 Years - | ChineseAMS | ||
Eligibility Screening for the NIH Intramural Research Program Clinical Protocols | NCT00026754 | Breast Cancer Prostate Cancer Lung Cancer Sarcoma Melanoma | 1 Month - | National Institutes of Health Clinical Center (CC) | ||
The Self-Collection Study: a Study of Self-collected HPV Testing and Results Counseling | NCT01843478 | HIV Infection | Self-Collected ... Usual Care | 18 Years - | Johns Hopkins University | |
Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies | NCT01567722 | Lung Cancer Lymphoma | DNA analysis RNA analysis gene expression... polymorphism an... biologic sample... flow cytometry medical chart r... | 18 Years - | AIDS Malignancy Consortium | |
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection | NCT01249443 | HIV Infection Recurrent Anal ... Recurrent Breas... Recurrent Esoph... Recurrent Gastr... Recurrent Metas... Recurrent Non-s... Recurrent Ovari... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Salivary Gland ... Stage IV Anal C... Stage IV Breast... Stage IV Esopha... Stage IV Gastri... Stage IV Non-sm... Stage IV Ovaria... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Unspecified Adu... | vorinostat diagnostic labo... pharmacological... carboplatin paclitaxel | 18 Years - | AIDS Malignancy Consortium | |
Human Papilloma Virus Infection in HIV-Positive Indian Men Who Have Sex With Men | NCT00919997 | Nonneoplastic C... Precancerous Co... | DNA analysis polymerase chai... fluorescence ac... questionnaire a... study of socioe... study of high r... | 18 Years - | AIDS Malignancy Consortium | |
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma | NCT01016730 | AIDS-Related Ka... HIV Infection Recurrent Kapos... | Bortezomib Laboratory Biom... Questionnaire A... | 18 Years - | National Cancer Institute (NCI) | |
Genetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alcoholism and Psychological Traits, and Histocompatibility Antigens | NCT00001294 | Alcoholism HIV Infection Homosexuality Kaposi's Sarcom... | - | National Institutes of Health Clinical Center (CC) | ||
Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection | NCT03202992 | HSIL, High-Grad... Human Papilloma... HIV Infection Anal Cancer Anus Neoplasms | ABI-1968 | 27 Years - | Antiva Biosciences | |
Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV | NCT01946139 | Anal Cancer HIV Infection Human Papilloma... | comparison of s... laboratory biom... questionnaire a... quality-of-life... | 18 Years - | AIDS Malignancy Consortium | |
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study | NCT04949464 | HIV Infection Tobacco-Related... | Computed Tomogr... Smoking Cessati... | 45 Years - 80 Years | AIDS Malignancy Consortium | |
Evaluation of Brain Lesions in HIV-infected Patients for Diagnosis of Primary Central Nervous System Lymphoma | NCT00226304 | HIV Infections Lymphoma, AIDS-... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions | NCT02059499 | Anal Intraepith... High-grade Squa... HIV Infection | imiquimod fluorouracil questionnaire a... laboratory biom... | 21 Years - | AIDS Malignancy Consortium | |
Human Papillomavirus Infection and Related Anal Lesions in HIV-positive Men Who Have Sex With Men | NCT02287961 | Hiv Infection | Standard procto... High resolution... Biopsy(ies) dur... High Resolution... | 35 Years - 80 Years | ANRS, Emerging Infectious Diseases | |
Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer | NCT00968630 | Hematopoietic a... HIV Infection | Laboratory Biom... Leukapheresis | - | Fred Hutchinson Cancer Center | |
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma | NCT05077527 | AIDS-Related Di... AIDS-Related No... HIV Infection Recurrent Diffu... Recurrent Grade... Recurrent High ... Recurrent Non-H... Recurrent Prima... Recurrent Trans... Refractory Diff... Refractory Grad... Refractory High... Refractory Non-... Refractory Prim... Refractory Tran... | Axicabtagene Ci... Cyclophosphamid... Fludarabine | 18 Years - | AIDS Malignancy Consortium | |
Cabozantinib S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus | NCT01822522 | Advanced Malign... HIV Infection Metastatic Mali... Recurrent Malig... Unresectable So... | Cabozantinib S-... Laboratory Biom... Pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
Evaluation of Brain Lesions in HIV-infected Patients for Diagnosis of Primary Central Nervous System Lymphoma | NCT00226304 | HIV Infections Lymphoma, AIDS-... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia | NCT01164722 | Anal Cancer Neoplasm of Unc... Nonneoplastic C... Precancerous Co... | clinical observ... infrared photoc... | 27 Years - | AIDS Malignancy Consortium | |
Gene-Modified HIV-Protected Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma | NCT02378922 | AIDS-Related Ho... AIDS-Related No... HIV Infection Recurrent Hodgk... Recurrent Non-H... | Gene-Modified H... Laboratory Biom... Transplant Cond... | 18 Years - 66 Years | Fred Hutchinson Cancer Center | |
Treatment With Immunological Checkpoint Inhibitors of HIV-infected Subjects With Cancer | NCT03767465 | HIV Infection Cancer | - | IrsiCaixa | ||
Cohort of HIV Associated Lymphomas | NCT01164436 | HIV Infection | 18 Years - 65 Years | ANRS, Emerging Infectious Diseases | ||
PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma | NCT00686842 | Kaposi's Sarcom... | VEGF inhibitor ... gene expression... polymerase chai... protein express... immunohistochem... laboratory biom... pharmacological... biopsy | 18 Years - 120 Years | AIDS Malignancy Consortium | |
Comparing Two Types of Swabs in Collecting Cell Samples for Anal Pap Tests and Human Papillomavirus Tests in Men Who Have Sex With Men | NCT00955591 | Anal Cancer Nonneoplastic C... Precancerous Co... | Papanicolaou te... | 18 Years - | Jonsson Comprehensive Cancer Center | |
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection | NCT02109224 | Adult B Acute L... Chronic Lymphoc... Cutaneous B-Cel... Extranodal Marg... HIV Infection Intraocular Lym... Multicentric An... Nodal Marginal ... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Grade... Recurrent Grade... Recurrent Mantl... Recurrent Margi... Recurrent Small... Refractory Chro... Refractory Hair... Refractory Plas... Small Intestina... Splenic Margina... Testicular Lymp... Waldenstrom Mac... | Ibrutinib Laboratory Biom... Pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
Human Papillomavirus Infection and Related Anal Lesions in HIV-positive Men Who Have Sex With Men | NCT02287961 | Hiv Infection | Standard procto... High resolution... Biopsy(ies) dur... High Resolution... | 35 Years - 80 Years | ANRS, Emerging Infectious Diseases | |
Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies | NCT01567722 | Lung Cancer Lymphoma | DNA analysis RNA analysis gene expression... polymorphism an... biologic sample... flow cytometry medical chart r... | 18 Years - | AIDS Malignancy Consortium | |
Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist | NCT00001475 | Acquired Immuno... HIV Infection | IL-2 plus Anti-... | - | National Institutes of Health Clinical Center (CC) | |
Seville Cohort of People Living With HIV at Risk for Anal Cancer | NCT03713229 | Anal Squamous I... | Screening for a... | 18 Years - | Hospitales Universitarios Virgen del Rocío | |
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study | NCT04949464 | HIV Infection Tobacco-Related... | Computed Tomogr... Smoking Cessati... | 45 Years - 80 Years | AIDS Malignancy Consortium | |
Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas | NCT01193842 | AIDS-Related Pl... AIDS-Related Pr... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... HIV Infection Plasmablastic L... Primary Effusio... Recurrent Diffu... Recurrent Grade... | Cyclophosphamid... Doxorubicin Hyd... Etoposide Laboratory Biom... Pharmacological... Prednisone Rituximab Vincristine Sul... Vorinostat | 18 Years - | National Cancer Institute (NCI) | |
Evaluation of Brain Lesions in HIV-infected Patients for Diagnosis of Primary Central Nervous System Lymphoma | NCT00226304 | HIV Infections Lymphoma, AIDS-... | 18 Years - | National Institutes of Health Clinical Center (CC) |